Evidence map›Paper›PMID 38584121›Full record

ArticleHuman vaccines & immunotherapeutics2024

A case of congenital rubella syndrome and epidemiology of related cases in China, 2014-2023.

Xiaoying Gong, Canjie Zheng, Quanjun Fang, Wenjie Xu, Zhiying Yin

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaoying GongDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.ORCID 0009-0009-7214-5931
Canjie ZhengDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Quanjun FangDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Wenjie XuDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Zhiying YinDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.ORCID 0000-0002-7678-5989
Taiwan Centers for Disease Control · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rubella is a major cause of congenital defects, and the presence of rubella infection in a pregnant woman may lead to fetal death or congenital defects known as congenital rubella syndrome(CRS). Since China has not yet established a national CRS surveillance system, the true incidence cannot be determined. To understand the disease burden and epidemiological characteristics of CRS cases in China, the article reports the first case of CRS in Quzhou, China, and conducts a retrospective analysis of related cases that have been reported in China over the past decade. Because the availability of rubella-containing vaccines (RCV) was not widespread in China before 2008, women of childbearing age born before 2008 are generally unvaccinated against RCV. Due to the lack of routine CRS monitoring and screening, CRS is underreported in China. Vaccination of nonimmune women of childbearing age with RCV and establishing a sensitive and timely case-based CRS surveillance system can accelerate the elimination of rubella and CRS.

Indexed as

RubellaRubella Syndrome, CongenitalFemaleHumansInfantPregnancyRetrospective StudiesRubella VaccineRubella virusRubella VaccineChinacongenital rubella syndromeRubellarubella-containing vaccinesurveillance system

Identifiers

PMID38584121
PMCPMC11000605
OpenAlexW4394575008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.